Pathology Laboratories, Inc. (PathLabs) is pleased to announce that we are bringing the STD (Sexually Transmitted Disease) testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV) of urine specimens in-house effective December 27, 2022.
As a result of internalizing this testing, there are updates to our Urine STD tests; specifically for methodology, decreased analytic time, new collection devices, longer stability, and certain EMR code changes. In addition, Urine STD testing is no longer gender specific. However, an order code has been established for a male test for Trichomonas, using a swab collection device.
All testing updates are disclosed in the context of this publication and the chart provided below.